Mufin Green Finance Q1 Results: Net profit rises 345.6% YoY to ₹14.01 Cr
Mufin Green Finance posted a 345.6% YoY net profit surge to ₹14.01 Cr in Q1FY27, fueled by 64.3% NII growth and 17.2% lower operating expenses. AUM expanded 69.4% to ₹1,599.23 Cr with GNPA at 1.91%. Cost of borrowings fell to 11.17%, enhancing margins.

*this image is generated using AI for illustrative purposes only.
Mufin Green Finance reported a 345.6% year-on-year increase in net profit after tax (PAT) to ₹14.01 crore for the quarter ended June 30, 2026, signaling robust profitability momentum in its first quarter of FY27. The financial performance was anchored by a 64.3% rise in net interest income (NII) to ₹35.16 crore, supported by disciplined cost management that saw operating expenses decline 17.2% to ₹13.55 crore despite a 61.8% jump in interest income. This divergence between revenue growth and expense contraction highlights significant operating leverage achieved through the company’s digital-first, branch-light model.
The filing, submitted under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, discloses that profit before tax (PBT) surged 345.6% to ₹18.82 crore from ₹4.22 crore in Q1FY26. Pre-provisioning operating profit (PPOP) more than doubled to ₹62.98 crore, up 102.3% year-on-year. While provisions and write-offs increased 167.6% to ₹2.89 crore, they remained manageable relative to the top-line expansion, allowing bottom-line metrics to expand sharply. The company’s capital adequacy ratio (CRAR) stood at a robust 30.55%, providing a strong buffer against credit risks.
Portfolio Expansion and Asset Quality
Total assets under management (AUM) reached ₹1,599.23 crore as of June 2026, reflecting a 69.4% growth from ₹944 crore in Q1FY26. Disbursements in Q1FY27 totaled ₹449.40 crore, up 37.3% year-on-year. Gross non-performing assets (GNPA) remained stable at 1.91%, indicating that rapid scale-up has not compromised asset quality. The portfolio is diversified across four verticals, with Mediclaim Financing contributing 42% of AUM, followed by MSME & Corporate loans at 29%, Climate Financing at 26%, and Salary Saathi at 3%.
| Vertical | AUM Share | Key Metric |
|---|---|---|
| Mediclaim Financing | 42% | ₹676.61 Cr AUM; +56.2% YoY disbursement |
| MSME & Corporate | 29% | ₹458.84 Cr AUM; 100% collateral-backed |
| Climate Financing | 26% | ₹410.83 Cr AUM; IoT-backed monitoring |
| Salary Saathi | 3% | ₹52.97 Cr AUM; Near-zero default risk |
Mediclaim Financing emerged as the primary growth driver, with disbursements rising 56.2% to ₹247.08 crore and loan counts increasing 48.4% to 48,214. June 2026 alone saw a 74.6% year-on-year jump in loan counts, reflecting accelerating point-of-sale adoption. Meanwhile, the Salary Saathi vertical, secured through salary deduction-at-source MoUs with state governments, grew 38.4% quarter-on-quarter to ₹38.20 crore, driven largely by expansion into Assam.
Funding Strategy and Operational Efficiency
The company strengthened its funding base by onboarding Union Bank and Wint Wealth in June 2026, securing a ₹25.00 crore term loan and a ₹100.00 crore NCD facility. Total borrowings stood at ₹1,550.99 crore across 35+ lenders, with the cost of borrowings declining to 11.17% in Q1FY27 from 12.17% in Q4FY26. This reduction in funding costs directly contributed to margin expansion. The borrowing mix shifted towards Non-Convertible Debentures (NCDs), which now constitute 24% of total borrowings, up from 16% in March 2025.
Operational efficiency gains were evident in headcount optimization. Cumulative disbursements grew 6.9x to ₹2,217 crore since Q1FY26, while headcount fell 26.45% from 499 to 367 employees. This resulted in disbursement per employee rising to ₹6.04 crore, underscoring the scalability of its tech-led infrastructure. Credit ratings remain positive, with Acuité maintaining an A- (Stable) rating and CRISIL assigning an A+ (SO) rating to its securitized pools.
What the Numbers Show
The most striking analytical observation is the decoupling of revenue growth from operational costs. While interest income jumped 61.8%, operating expenses contracted 17.2%. This suggests that Mufin Green Finance is successfully leveraging fixed-cost digital platforms to absorb volume growth without proportional increases in staffing or overheads. Furthermore, the decline in cost of borrowings (from 12.17% to 11.17%) combined with stable GNPA levels indicates that the company is not merely growing volume but improving unit economics. The heavy reliance on Mediclaim financing (42% of AUM) presents a concentration risk, but the low Loss Given Default (LGD) of 1% ± 0.25% assigned by CRISIL mitigates this concern, validating the asset quality of this high-growth segment.
Historical Stock Returns for Mufin Green Finance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.31% | +2.16% | +4.42% | +15.35% | +53.15% | +1.10% |
How might the concentration of 42% of AUM in Mediclaim Financing expose Mufin Green Finance to regulatory changes in the health insurance sector?
What impact could the shift towards Non-Convertible Debentures (NCDs) have on the company's liquidity profile and refinancing risks in a rising interest rate environment?
Can the current operating leverage model sustain profitability if disbursement growth slows down, given the fixed-cost digital infrastructure?


































